Quiros-Cano, M., Sanz, L., Parra-Martinez, C., Gasca, J., Medina-Caliz, I., Martin-Reyes, F., … Andrade, R. J. (2018). The Livertox® Categorization of Drug Hepatotoxic Potential. a Critical Appraisal. In HEPATOLOGY (Vol. 68, pp. 202A-202A).

Quiros-Cano, M., Laura Sanz, C. Parra-Martinez, J. Gasca, I. Medina-Caliz, F. Martin-Reyes, J. Sanabria-Cabrera, et al. “The Livertox® Categorization of Drug Hepatotoxic Potential. a Critical Appraisal.” In HEPATOLOGY, 68:202A-202A, 2018.

Quiros-Cano M, Sanz L, Parra-Martinez C, Gasca J, Medina-Caliz I, Martin-Reyes F, et al. The Livertox® Categorization of Drug Hepatotoxic Potential. a Critical Appraisal. In: HEPATOLOGY. 2018. p. 202A-202A.

Quiros-Cano, M., et al. “The Livertox® Categorization of Drug Hepatotoxic Potential. a Critical Appraisal.” HEPATOLOGY, vol. 68, 2018, pp. 202A-202A.

Quiros-Cano M, Sanz L, Parra-Martinez C, Gasca J, Medina-Caliz I, Martin-Reyes F, Sanabria-Cabrera J, Gonzalez-Jimenez A, Robles-Diaz M, Sanjuan-Jimenez R, Cueto-Sanchez A, Martinez-Gomez E, Ortega-Alonso A, Garcia-Cortes M, Aithal GP, Suzuki A, Lucena M, Andrade RJ. The Livertox® Categorization of Drug Hepatotoxic Potential. a Critical Appraisal. HEPATOLOGY. 2018. p. 202A-202A.